Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19, Presented at the European Congress of Clinical Microbiology & Infectious Diseases Pharmaceutical Investing
Collaboration Between AbbVie, Biogen and Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease Biotech Investing
Cardiol Therapeutics' Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman Biotech Investing
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology Cannabis Investing News
Knight Therapeutics Announces Health Canada Approval for NERLYNX® to Treat HER2-Positive Metastatic Breast Cancer Medical Device Investing
Bausch Health Companies Inc. Will Release Second-Quarter 2021 Financial Results On August 3 Medical Device Investing
FDA Approves Expanded Indication for Merck's KEYTRUDA® in Locally Advanced Cutaneous Squamous Cell Carcinoma Pharmaceutical Investing
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories Pharmaceutical Investing
Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets Cannabis Investing News
